Current understanding of congenital myasthenic syndromes

Current Opinion in Pharmacology

Volumn 5, Issue 3 SPEC. ISS., 2005, Pages 308-321

  Engel, Andrew G ^a   Sine, Steven M ^b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIAMINOPYRIDINE; ACETAZOLAMIDE; ACETYLCHOLINESTERASE; CARRIER PROTEIN; CHOLINERGIC RECEPTOR; CHOLINESTERASE INHIBITOR; FLUOXETINE; MUTANT PROTEIN; NEOSTIGMINE METHYL SULFATE; PROTEIN TYROSINE KINASE; PYRIDOSTIGMINE; QUINIDINE SULFATE; RAPSYN;

ARTICLE; BIOCHEMISTRY; CONGENITAL MYASTHENIC SYNDROME; CRYSTALLOGRAPHY; DISEASE CLASSIFICATION; DRUG MECHANISM; GENE TARGETING; HUMAN; MEMBRANE ELECTROPHYSIOLOGY; MORPHOLOGY; MUTATIONAL ANALYSIS; MYASTHENIA; NERVE ENDING; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 18744401389     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2004.12.007     Document Type: Review

References (81)

1. M.M. Salpeter Vertebrate neuromuscular junctions: General morphology, molecular organization, and functional consequences In The Vertebrate Neuromuscular Junction Edited by M.M. Salpeter 1987 Alan Liss New York 1-54
2. + channels and ankyrin in neuromuscular junctions is complementary to that of acetylcholine receptors and the 43 kd protein Neuron 3 1989 163-175
3. R.L. Ruff Sodium channel slow inactivation and the distribution of sodium channels on skeletal muscle fibres enable the performance properties of different skeletal muscle fiber types Acta Physiol Scand 156 1996 159-168
4. S.J. Wood C.P. Slater Safety factor at the neuromuscular junction Prog Neurobiol 64 2001 393-429
5. A.G. Engel K. Ohno S.M. Sine Congenital myasthenic syndromes In Myology Edited by A.G. Engel C. Franzini-Armstrong 3rd edn 2004 McGraw-Hill New York 1755-1790
6. K. Ohno A. Tsujino J.M. Brengman C.M. Harper Z. Bajzer B. Udd R. Beyring S. Robb F.J. Kirkham A.G. Engel Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans Proc Natl Acad Sci USA 98 2001 2017-2022
7. R.F. Byring H. Pihko X-M. Shen B. Gustafsson P. Hackman K. Ohno A.G. Engel B. Udd Congenital myasthenic syndrome associated with episodic apnea and sudden infant death Neuromuscul Disord 12 2002 548-553
8. R.A. Maselli D. Chen D. Mo C. Bowe G. Fenton R.L. Wollman Choline acetyltransferase mutations in myasthenic syndrome due to deficient acetycholine resynthesis Muscle Nerve 27 2003 180-187
9. C. Schmidt A. Abicht K. Krampfl W. Voss R. Stucka G. Mildner S. Petrova U. Schara W. Mortier J. Bufler et al. Congenital myasthenic syndrome due to a novel missense mutation in the gene encoding choline acetyltransferase Neuromuscul Disord 13 2003 245-251
10. Y. Cai C.N. Cronin A.G. Engel K. Ohno L.B. Hersh D. Rodgers Choline acetyltransferase structure reveals distribution of mutations that cause motor disorders EMBO J 23 2004 2047-2058
11. L. Govindasamy B. Pedersen W. Lian Y. Kukar Y. Gu S. Jin M. Agbandje-McKenna D. Wu R. McKenna Structural insights and functional implications of choline acetyltransferase J Struct Biol 148 2004 226-235
12. A.G. Engel E.H. Lambert M.R. Gomez A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release Ann Neurol 1 1977 315-330
13. S. Bon F. Coussen J. Massoulié Quaternary associations of acetylcholinesterase. II. The polyproline attachment domain of the collagen tail J Biol Chem 272 1997 3016-3021
14. K. Ohno J.M. Brengman A. Tsujino A.G. Engel Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme Proc Natl Acad Sci USA 95 1998 9654-9659
15. C. Donger E. Krejci P. Serradell B. Eymard S. Bon S. Nicole D. Chateau F. Gary M. Fardeau J. Massoulié P. Guicheney Mutation in the human acetylcholinesterase-associated gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency Am J Hum Genet 63 1998 967-975
16. K. Ohno D.O. Hutchinson M. Milone J.M. Brengman C. Bouzat S.M. Sine A.G. Engel Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the ε subunit Proc Natl Acad Sci USA 92 1995 758-762
17. M. Milone H.-L. Wang K. Ohno T. Fukudome J.N. Pruitt N. Bren S.M. Sine A.G. Engel Slow-channel syndrome caused by enhanced activation, desensitization, and agonist binding affinity due to mutation in the M2 domain of the acetylcholine receptor alpha subunit J Neurosci 17 1997 5651-5665
18. S.M. Sine K. Ohno C. Bouzat A. Auerbach M. Milone J.N. Pruitt A.G. Engel Mutation of the acetylcholine receptor α subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity Neuron 15 1995 229-239
19. A.G. Engel K. Ohno M. Milone H.-L. Wang S. Nakano C. Bouzat J.N. Pruitt D.O. Hutchinson J.M. Brengman N. Bren J.P. Sieb S.M. Sine New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome Hum Mol Genet 5 1996 1217-1227
20. H.-L. Wang A. Auerbach N. Bren K. Ohno A.G. Engel S.M. Sine Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation J Gen Physiol 109 1997 757-766
21. C.M. Gomez R. Maselli J. Gammack J. Lasalde S. Tamamizu D.R. Cornblath M. Lehar M.G. McNamee R. Kuncl A beta-subunit mutation in the acetylcholine receptor gate causes severe slow-channel syndrome Ann Neurol 39 1996 712-723
22. R. Croxen C. Newland D. Beeson H. Oosterhuis G. Chauplanaz A. Vincent J. Newsom-Davis Mutations in different functional domains of the human muscle acetylcholine receptor α subunit in patients with the slow-channel congenital myasthenic syndrome Hum Mol Genet 6 1997 767-774
23. K. Ohno M. Milone J.M. Brengman M. Lo Monaco A. Evoli P. Tonali A.G. Engel Slow-channel congenital myasthenic syndrome caused by a novel mutation in the acetylcholine receptor ε subunit [abstract] Neurology 50 1998 A432
24. K. Ohno H.-L. Wang X.-M. Shen M. Milone L. Bernasconi S.M. Sine A.G. Engel Slow-channel mutations in the center of the M1 transmembrane domain of the acetylcholine receptor α subunit [abstract] Neurology 54 Suppl 3 2000 A183
25. C.M. Gomez R. Maselli J. Staub J.W. Day T. Cens R.L. Wollman P.C. Charnet Novel δ and β subunit acetylcholine receptor mutations in the slow-channel syndrome demonstrate phenotypic variability [abstract] Soc Neurosci Abstr 24 1998 484
26. C.M. Gomez R. Maselli Vohra BPS M. Navedo J.R. Stiles P. Charnet K. Schott L. Rojas J. Keesey A. Verity R.W. Wollman J. Lasalde-Dominici Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanism Ann Neurol 51 2002 102-112
27. C.J. Hatton C. Shelley M. Brydson D. Beeson D. Colquhoun Properties of the human muscle nicotinic receptor, and of the slow-channel myasthenic syndrome mutant εL221F, inferred from maximum likelihood fits J Physiol (Lond) 547 2003 729-760
28. R. Webster M. Brydson R. Croxen J. Newsom-Davis A. Vincent D. Beeson Mutation in the AChR channel gate underlies a fast channel congenital myasthenic syndrome Neurology 62 2004 1090-1096
29. S.M. Sine X-M. Shen H-L. Wang K. Ohno W-Y. Lee A. Tsujino J.M. Brengman N. Bren J. Vajsar A.G. Engel Naturally occurring mutations at the acetylcholine receptor binding site independently alter ACh binding and channel gating J Gen Physiol 120 2002 483-496
30. K. Ohno H-L. Wang M. Milone N. Bren J.M. Brengman S. Nakano P. Quiram J.N. Pruitt S.M. Sine A.G. Engel Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor ε subunit Neuron 17 1996 157-170
31. S. Brownlow R. Webster R. Croxen M. Brydson B. Neville J-P. Lin A. Vincent J. Newsom-Davis D. Beeson Acetylcholine receptor δ subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita J Clin Invest 108 2001 125-130
32. X-M. Shen K. Ohno A. Tsujino J.M. Brengman M. Gingold S.M. Sine A.G. Engel Mutation causing severe myasthenia reveals functional asymmetry of AChR signature Cys-loops in agonist binding and gating J Clin Invest 111 2003 497-505
33. H-L. Wang M. Milone K. Ohno X-M. Shen A. Tsujino A.P. Batocchi P. Tonali J.M. Brengman A.G. Engel S.M. Sine Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating Nature Neurosci 2 1999 226-233
34. M. Milone H-L. Wang K. Ohno R.J. Prince X-M. Shen J.M. Brengman R.C. Griggs A.G. Engel Mode switching kinetics produced by a naturally occurring mutation in the cytoplasmic loop of the human acetylcholine receptor ε subunit Neuron 20 1998 575-588
35. H.-L. Wang K. Ohno M. Milone J.M. Brengman A. Evoli A.P. Batocchi L. Middleton K. Christodoulou A.G. Engel S.M. Sine Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome J Gen Physiol 116 2000 449-460
36. K. Brejc W.V. van Dijk M. Schuurmans J. van der Oost A.B. Smit T.K. Sixma Crystal structure of ACh-binding protein reveals the ligand-binding domain of nicotinic receptors NAT 411 2001 269-276
37. A. Miyazawa Y. Fujiyoshi N. Unwin Structure and gating mechanism of the acetylcholine receptor pore NAT 424 2003 949-955
38. C. Bouzat F. Gumilar G. Spitzmaul H.-L. Wang D. Rayes S.B. Hansen P. Taylor S.M. Sine Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel NAT 430 2004 896-900
39. N. Unwin Refined structure of the nicotinic acetylcholine receptor at 4 Å resolution J Mol Biol 346 2005 967-989
40. A.G. Engel K. Ohno C. Bouzat S.M. Sine R.G. Griggs End-plate acetylcholine receptor deficiency due to nonsense mutations in the ε subunit Ann Neurol 40 1996 810-817
41. K. Ohno P. Quiram M. Milone H-L. Wang C.M. Harper J.N. Pruitt J.M. Brengman L. Pao K.H. Fischbeck T.O. Crawford S.M. Sine A.G. Engel Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor ε subunit gene: identification and functional characterization of six new mutations Hum Mol Genet 6 1997 753-766
42. J. Cossins R. Webster S. Maxwell G. Burke A. Vincent D. Beeson A mouse model of AChR deficiency syndrome with a phenotype reflecting the human conditions Hum Mol Genet 13 2004 2947-2957
43. K. Ohno B. Anlar E. Özdirim J.M. Brengman J.L. De Bleecker A.G. Engel Myasthenic syndromes in Turkish kinships due to mutations in the acetylcholine receptor Ann Neurol 44 1998 234-241
44. A. Abicht R. Stucka V. Karcagi A. Hercegfalvi R. Horváth W. Mortier U. Schara V. Ramaekers W. Jost J. Brunner et al. A common mutation (ε1267delG) in congenital myasthenic patients of Gypsy ethnic origin Neurology 53 1999 1564-1569
45. L. Middleton K. Ohno K. Christodoulou J.M. Brengman M. Milone V. Neocleous P. Serdaroglu F. Deymeer C. Özdemir A. Mubaidin et al. Congenital myasthenic syndromes linked to chromosome 17p are caused by defects in acetylcholine receptor ε subunit gene Neurology 53 1999 1076-1082
46. R. Croxen C. Newland M. Betty A. Vincent J. Newsom-Davis D. Beeson Novel functional ε-subunit polypeptide generated by a single nucleotide deletion in acetylcholine receptor deficiency congenital myasthenic syndrome Ann Neurol 46 1999 639-647
47. X.-M. Shen K. Ohno T. Fukudome A. Tsujino J.M. Brengman D.C. De Vivo R.J. Packer A.G. Engel Congenital myasthenic syndrome caused by low-expressor fast-channel AChR δ subunit mutation Neurology 59 2002 1881-1888
48. J. Ealing R. Webster S. Brownlow A. Abdelgany H. Oosterhuis F. Muntoni D.J. Vaux A. Vincent D. Beeson Mutations in congenital myasthenic syndromes reveal an ε subunit C-terminal cysteine, C470, crucial for maturation and surface expressions of adult AChR Hum Mol Genet 11 2002 3087-3096
49. K. Ohno B. Anlar C. Ozdemir J.M. Brengman A.G. Engel Frameshifting and splice-site mutations in acetylcholine receptor ε subunit gene in 3 Turkish kinships with congenital myasthenic syndromes Ann N Y Acad Sci 841 1998 189-194
50. A. Abicht R. Stucka C. Schmidt A. Briguet I-H. Song D. Pongratz W. Müller-Felber M.A. Ruegg H. Lochmüller A newly identified chromosomal microdeletion and an N-box mutation of the AChRε gene cause a congenital myasthenic syndrome Brain 125 2002 1005-1013
51. K. Ohno B. Anlar A.G. Engel Congenital myasthenic syndrome caused by a mutation in the Ets-binding site of the promoter region of the acetylcholine receptor ε subunit gene Neuromuscul Disord 9 1999 131-135
52. P.R. Nichols R. Croxen A. Vincent R. Rutter M. Hutchinson J. Newsom-Davis D. Beeson Mutation of the acetylcholine receptor ε-subunit promoter in congenital myasthenic syndrome Ann Neurol 45 1999 439-443
53. A. Duclert N. Savatier L. Schaeffer J-P. Changeux Identification of an element crucial for the sub-synaptic expression of the acetylcholine receptor epsilon-subunit gene J Biol Chem 271 1996 17433-17438
54. L. Schaeffer N. Duclert M. Huchet-Dymanus J.-P. Changeux Implication of a multisubunit Ets-related transcription factor in synaptic expression of the nicotinic acetylcholine receptor EMBO J 17 1998 3078-3090
55. L. Fromm S.J. Burden Synapse-specific and neuregulin-induced transcription require an Ets site that binds GABPα/GAPBβ Genes Dev 12 1998 3074-3083
56. P. Quiram K. Ohno M. Milone M.C. Patterson N.J. Pruitt J.M. Brengman S.M. Sine A.G. Engel Mutation causing congenital myasthenia reveals acetylcholine receptor β/δ subunit interaction essential for assembly J Clin Invest 104 1999 1403-1410
57. K. Ohno A.G. Engel Congenital myasthenic syndromes: Gene mutations Neuromuscul Disord 14 2004 117-122
58. K. Ohno A.G. Engel X-M. Shen D. Selcen J.M. Brengman C.M. Harper A. Tsujino M. Milone Rapsyn mutations in humans cause endplate acetylcholine receptor deficiency and myasthenic syndrome Am J Hum Genet 70 2002 875-885
59. P. Richard K. Gaudon F. Andreux E. Yasaki C. Prioleau S. Bauché et al. Possible founder effect of rapsyn N88K mutation and identification of novel rapsyn mutations in congenital myasthenic syndromes J Med Genet 2003 [URL: http://jmg.bmjjournals.com/cgi/reprint/ 40/6/e81]
60. J.S. Müller A. Abicht G. Burke J. Cossins P. Richard S.K. Baumesiter R. Stucka B. Eymard D. Hantai D. Beeson H. Lochmüller The congenital myasthenic syndrome mutation RAPSN N88K derives from an ancient Indo-European founder J Med Genet 41 2004 [URL: http://jmg.bmjjournals.com/cgi/reprint/41/8/e104]
61. K. Ohno A.G. Engel Lack of founder haplotype for the rapsyn mutation: N88K is an ancient founder mutation or arises from multiple founders J Med Genet 41 2004 [URL: http://jmg.bmjjournals.com/cgi/content/full/41/1/ e8]
62. K. Ohno M. Sadeh I. Blatt J.M. Brengman A.G. Engel E-box mutations in RAPSN promoter region in eight cases with congenital myasthenic syndrome Hum Mol Genet 12 2003 739-748
63. G. Burke J. Cossins S. Maxwell G. Owens A. Vincent S. Robb M. Nicolle D. Hilton-Jones J. Newsom-Davis J. Palace D. Beeson Rapsyn mutations in hereditary myasthenia. Distinct early- and late-onset phenotypes Neurology 61 2003 826-828
64. F. Chevessier B. Faraut A. Ravel-Chapuis P. Richard K. Gaudon S. Bauche C. Prioleau R. Herbst E. Goillot C. Ioos et al. MUSK, a new target for mutations causing congenital myasthenic syndrome Hum Mol Genet 13 2004 3229-3240
65. A. Tsujino C. Maertens K. Ohno X.-M. Shen T. Fukuda C.M. Harper S.C. Cannon A.G. Engel Myasthenic syndrome caused by mutation of the SCN4A sodium channel Proc Natl Acad Sci USA 100 2003 7377-7382
66. T. Fukudome K. Ohno J.M. Brengman A.G. Engel Quinidine normalizes the open duration of slow-channel mutants of the acetylcholine receptor Neuroreport 9 1998 1907-1911
67. C.M. Harper A.G. Engel Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome Ann Neurol 43 1998 480-484
68. C.M. Harper T. Fukudome A.G. Engel Treatment of slow channel congenital myasthenic syndrome with fluoxetine Neurology 60 2003 170-173
69. B.L. Banwell K. Ohno J.P. Sieb A.G. Engel Novel truncating RAPSN mutation causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine Neuromuscul Disord 14 2004 202-207
70. A.G. Engel K. Ohno S.M. Sine Congenital myasthenic syndromes: Progress over the past decade Muscle Nerve 27 2003 4-25
71. H. Dvir M. Harel S. Bon W.-Q. Liu M. Vidal C. Garbay J.L. Sussman J. Massoulie I. Silman The synaptic acetylcholinesterase tetramer assembles around a proline II helix EMBO J 23 2004 4394-4405
72. P.N. Deprez N.C. Inestrosa Two heparin-binding domains are present on the collagenic tail of asymmetric acetylcholinesterase J Biol Chem 270 1995 11043-11046
73. K. Ohno A.G. Engel J.M. Brengman C.M. Harper X.-M. Shen F.R. Heidenreich A. Vincent M. Milone E. Tan M. Demirci et al. The spectrum of mutations causing endplate acetylcholinesterase deficiency Ann Neurol 47 2000 162-170
74. L.M. Kimbell K. Ohno A.G. Engel R.L. Rotundo C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse J Biol Chem 279 2004 10997-11005
75. E. Arikawa-Hirasawa S.G. Rossi R.L. Rotundo Y. Yamada Absence of acetylcholinesterase at the neuromuscular junction of perlecan-null mice Nature Neurosci 5 2002 119-123
76. A. Cartaud L. Strochlic M. Guerra B. Blanchard M. Lambergeon E. Kjerci C. Legay MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction J. Cell Biol 165 2004 505-515
77. M.K. Ramarao J.B. Cohen Mechanism of nicotinic acetylcholine receptor cluster formation by rapsyn Proc Natl Acad Sci USA 95 1998 4007-4012
78. M.K. Ramarao M.J. Bianchetta J. Lanken J.B. Cohen Role of rapsyn tetratricopeptide repeat and coiled-coil domains in self-association and nicotinic acetylcholine receptor clustering J Biol Chem 276 2001 7475-7483
79. M. Bartoli M.K. Ramarao J.B. Cohen Interactions of the rapsyn RING-H2 domain with dystroglycan J Biol Chem 276 2001 24911-24917
80. Y.I. Lee S.L. Swope M.J. Ferns Rapsyn's C-terminal domain mediates MuSK-induced phosphorylation of the AChR [abstract] Mol Biol Cell 13 2002 395a
81. R. Croxen C.J. Hatton C. Shelley M. Brydson G. Chauplannaz H. Oosterhuis A. Vincent J. Newsom-Davis D. Colquhoun D. Beeson Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes Neurology 59 2002 162-168